| Literature DB >> 30982734 |
Elsa Sanchez-Lopez1, Zhenyu Zhong2, Alexandra Stubelius3, Shannon R Sweeney4, Laela M Booshehri5, Laura Antonucci1, Ru Liu-Bryan6, Alessia Lodi7, Robert Terkeltaub6, Juan Carlos Lacal8, Anne N Murphy1, Hal M Hoffman5, Stefano Tiziani9, Monica Guma3, Michael Karin10.
Abstract
Choline is a vitamin-like nutrient that is taken up via specific transporters and metabolized by choline kinase, which converts it to phosphocholine needed for de novo synthesis of phosphatidylcholine (PC), the main phospholipid of cellular membranes. We found that Toll-like receptor (TLR) activation enhances choline uptake by macrophages and microglia through induction of the choline transporter CTL1. Inhibition of CTL1 expression or choline phosphorylation attenuated NLRP3 inflammasome activation and IL-1β and IL-18 production in stimulated macrophages. Mechanistically, reduced choline uptake altered mitochondrial lipid profile, attenuated mitochondrial ATP synthesis, and activated the energy sensor AMP-activated protein kinase (AMPK). By potentiating mitochondrial recruitment of DRP1, AMPK stimulates mitophagy, which contributes to termination of NLRP3 inflammasome activation. Correspondingly, choline kinase inhibitors ameliorated acute and chronic models of IL-1β-dependent inflammation.Entities:
Keywords: AMPK; CTL1; IL-18; IL-1β; NLRP3; choline; choline kinase; macrophages; mitochondrial lipids; mitophagy; phosphocholine
Year: 2019 PMID: 30982734 PMCID: PMC6675591 DOI: 10.1016/j.cmet.2019.03.011
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287